Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPTIMIZE GEN - Outcomes of Persistence and Treatment With tIrzepatide deterMined by Genetic, mIcrobiological & bEhavioral Factors in obEsity

NCT07650149 is registered in ClinicalTrials.gov with Jan Kochanowski University as lead sponsor.

NCT NCT07650149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07650149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPTIMIZE GEN - Outcomes of Persistence and Treatment With tIrzepatide deterMined by Genetic, mIcrobiological & bEhavioral Factors in obEsity
Lead sponsor
Jan Kochanowski University
Phase
Observational
Overall status
Recruiting
Start date
May 23, 2026
Completion date
May 31, 2028
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

genetics, obesity, obesity & overweight